• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.07% Nasdaq Up0.32%

    Endo International plc (ENDP)

    -NasdaqGS
    78.70 Down 0.30(0.38%) Aug 28, 4:00PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    Endo International plc
    Minerva House
    Simmonscourt Road
    Dublin, 4
    Ireland - Map
    Phone: 353 1 268 2000
    Website: http://www.endo.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drug Manufacturers - Other
    Full Time Employees:5,062

    Business Summary 

    Endo International plc, a specialty healthcare company, focuses on branded and generic pharmaceuticals and devices worldwide. It operates through four segments: U.S. Branded Pharmaceuticals, U.S. Generic Pharmaceuticals, Devices, and International Pharmaceuticals. The U.S. Branded Pharmaceuticals segment provides various branded prescription products, including Lidoderm, Opana ER, Voltaren Gel, Percocet, Frova, Fortesta Gel, Supprelin LA, Valstar, Vantas, Sumavel DosePro, Aveed, and Natesto to treat and manage pain and conditions in urology, endocrinology, and oncology. The U.S. Generic Pharmaceuticals segment offers products in the pain management, urology, CNS disorders, immunosuppression, oncology, women’s health, hypertension, generic lidocaine patch, and other markets. The Devices segment provides various medical devices comprising AMS 800 artificial urinary sphincters, AMS 700 MS series, Monarc subfascial hammock products, Elevate anterior and posterior pelvic floor repair systems, and GreenLight XPS laser systems in the areas of men’s and women’s pelvic health. The International Pharmaceuticals segment offers Dexedrine, Tridural, Metadol, Trandate, Pennsaid, and Plan B products in therapeutic areas, including attention deficit hyperactivity disorder, pain, urology, and allergy. It sells its branded pharmaceuticals and generics directly to large pharmacy chains; and through wholesale drug distributors to pharmacies, hospitals, governmental agencies, and physicians. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Endo International plc

    Corporate Governance 
    Endo International plc’s ISS Governance QuickScore as of Aug 1, 2015 is 9. The pillar scores are Audit: 2; Board: 5; Shareholder Rights: 4; Compensation: 10.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Mr. Rajiv Kanishka Liyanaarchchie De Silva , 48
    Chief Exec. Officer, Pres and Director
    16.62M0.00
    Mr. Suketu P. Upadhyay , 46
    Chief Financial Officer and Exec. VP
    3.73M0.00
    Ms. Caroline B. Manogue Esq., 46
    Consultant
    12.17M8.21M
    Ms. Julie B. Yankovich ,
    VP of Employee Communications & Bus. Operations
    N/AN/A
    Mr. Daniel A. Rudio ,
    Chief Accounting Officer, VP and Controller
    N/AN/A
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders